Aurobindo Pharma receives US FDA approval for Omeprazole delayed-release capsules
Omeprazole delayed-release capsules are indicated for short-term treatment of active duodenal ulcer in adults
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
Aurobindo Pharma posts Rs 3320.4-crore total operating income at Q1/FY2015-16
Profit after tax after minority interest was at Rs 432.4 crores Aurobindo Pharma has posted the unaudited consolidated financial…
Aurobindo Pharma receives US FDA approval for Esmolol Hydrochloride injection
Esmolol Hydrochloride injection is indicated for the short-term treatment of tachycardia and hypertension that occur during…
Aurobindo Pharma receives approval for Azithromycin for injection and Entacapone tabs
Azithromycin for injection is indicated for treatment of patients with community-acquired pneumonia and pelvic inflammatory…
Aurobindo Pharma gets US FDA nod for extended phenytoin sodium capsules
Phenytoin sodium extended capsules is an anti-epileptic product and indicated for the control of seizures and prevention and…
Aurobindo Pharma receives USFDA approval for Metronidazole tablets
Metronidazole tablets are used to treat different types of infections
Aurobindo Pharma posts Q4/FY2014-15 results
Total operating income was up by 35.7 per cent to Rs 3162.1 crores in Q4 FY2014-15 Aurobindo Pharma has posted its Q4/FY2014-15…
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Cabinet clears Rs 4,187-crore Glenmark, Aurobindo proposals
The decision was taken by CCEA, chaired by Prime Minister Narendra Modi
Aurobindo Pharma receives US FDA approval for Cefixime for oral suspension USP
Cefixime for oral suspension is indicated for the treatment of adults and paediatric patients six months of age or older